Navigation Links
Shrink Nanotechnologies Enters Into Agreement to Produce High Content Screening Software Called 'Stemage' for its StemDisc Stem Cell Culturing Products
Date:10/22/2010

CARLSBAD, Calif., Oct. 22 /PRNewswire/ -- Shrink Nanotechnologies, Inc. ("Shrink") (OTC Bulletin Board: INKN), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that it has entered into an agreement to produce a high content screening tool for its biotech R&D subsidiary, Shrink Chips LLC.  Stemage™ software will launch with StemDisc products; however the long term goal of the project is to build the world's first intuitive and integrated bio-informatics database to facilitate the acquisition and sharing of three-dimensional (3D) imaging and data to predict the best method for culturing embryoid bodies (EBs) and other cellular structures.

EBs are used to grow or regenerate stem cells and nearly any kind of tissue in the body – from muscles to eyes to lungs. EBs are used in a wide range of 2-D and 3-D cellular-based disease models for drug screening/testing, tissue engineering and personalized medicine. "The Human Genome Project, completed in 2003, ushered in one of the most profound changes to 20th century scientific research – the identification of the human genome sequence. While the sequence of human DNA is stored in databases worldwide, biologists are still struggling to interpret the data and meet the high-throughput demands of their stem cell research projects," said Mark L. Baum, CEO of Shrink Nanotechnologies, Inc.

StemDisc products – as hardware - will allow for the development of thousands of EBs on a single footprint well plate.  The success of our ability to create "EB data points" has actually presented another problem:  What does the biologist do with all of the data that is being created?  How can this data be rapidly collected, analyzed and even modeled?  Computing power is increasing ever rapidly.  

Beginning in the first week of November, Shrink will begin testing the image acquisition aspect of the Stemage software which will allow the user to center his or her microscope over the StemDisc, press "start" and have the software locate all of the individual microwells within the StemDisc system.  This system will eliminate the manual processes involved in data acquisition and will also save the user time by eliminating the need to "crop" out images and regions of interest.  At the same time, additional features and protocols for staining and imaging EBs in three dimensions are being finalized.  The Company believes that initial versions of the plug-in will be available at the time StemDisc is launched.  

When released, Shrink's bio-informatics tool will be downloaded as a plug-in to existing scope platforms. It is hoped that in the longer term, this project has the potential to aid in automated image analysis to extract 3D models of cell locations and concentrations of gene products of interest, eventually providing a much needed global repository for data processing, storing and analysis of specific cell culturing models.  Our goal is to allow today's disparate cell culturing models to be shared and interpreted worldwide with greater speed and efficiency, helping to drive down the costs of potentially life-saving biotech research," added Baum.

About Shrink Nanotechnologies, Inc.

Shrink Nanotechnologies, Inc. is a one-of-a-kind FIGA™ organization, which focuses on leveraging contributions from experts in Finance, Industry, Government and Academia. Operating as a high-technology development-stage company, Shrink owns and develops proprietary and patent-pending nano-sized technologies, components and product systems. The Company's unique NanoShrink™ material is a pre-stressed polymer which is used in a patent pending manufacturing platform with numerous applications in the solar energy, human and animal diagnostics, and biotechnology research and development tools industries. For more information, please visit www.shrinknano.com.

Statements contained herein that are not historical facts may be forward-looking statements within the meaning of the Securities Act of 1933, as amended. Forward-looking statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements are estimates only. Actual results may differ materially from those anticipated in this press release. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to Shrink's ability to obtain additional financing and to build and develop markets for Shrink's biotechnology technologies and products. These factors should be strongly considered when making a decision to acquire or maintain a financial interest in Shrink, including consulting with a FINRA registered representative prior to making such decision. Shrink undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in Shrink's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact Shrink's success are more fully disclosed in Shrink's most recent public filings with the U.S. Securities and Exchange Commission.

See also:

http://www.shrinksolar.com/blog/

http://www.shrinknano.com/products/product-tools

http://www.shrinknano.com/products/product-diagnostics

http://www.shrinknano.com/tech

http://www.shrinknano.com/tr35-a-children%E2%80%99s-toy-inspires-a-cheap-easy-production-method-for-high-tech-diagnostic-chips

Contact:

For Shrink Nanotechnologies

Mark L. Baum, Esq.

760-804-8844 x205

(Logo: http://photos.prnewswire.com/prnh/20101015/SHRINKLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20101015/SHRINKLOGO)


'/>"/>
SOURCE Shrink Nanotechnologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shrink Nanotechnologies Unveils Product Image of Initial StemDisc450 Prototype
2. The nano world of Shrinky Dinks
3. Novel CU-Boulder technique shrinks size of nanotechnology circuitry
4. REXIN-G Shrinks Metastatic Tumors and Triples Survival Time in Chemotherapy-Resistant Pancreatic Cancer: Analysis of a U.S. Phase I/II Clinical Trial (Proceedings of ASCO GI Symposium 2009)
5. Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes
6. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
7. NSF renews Centers for Nanotechnology in Society
8. Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement
9. ReGear Life Sciences Partners with Life Care Centers of America
10. Safran Enters Into a Definitive Agreement With L-1 Identity Solutions for the Purchase of L-1 Biometrics and ID Management Solutions Businesses
11. Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):